Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L McKim

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Business Continuity & Emergency Planning|June 15, 2017
Operational risk assessmentVicky L McKim
The Lamp|February 20, 1999
Applause for Sydney Hospital UnitD Erickson, L McKim, P Griswold
Environmental and Molecular Mutagenesis|July 30, 2017
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomasBarbara L Parsons, Karen L McKim, Meagan B Myers
Molecular Carcinogenesis|August 30, 2012
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroidMeagan B Myers, Karen L McKim, Barbara L Parsons
Personalized Medicine|March 1, 2015
Low-frequency <i>KRAS</i> mutations are prevalent in lung adenocarcinomasMeagan B Myers, Karen L McKim, Fanxue Meng, et al.
Expert Review of Molecular Diagnostics|August 1, 2012
Hotspot oncomutations: implications for personalized cancer treatmentMeagan B Myers, Yiying Wang, Karen L McKim, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2020
ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver MutationsMeagan B Myers, Karen L McKim, Yiying Wang, et al.
Plos One|September 8, 2020
Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoidsMalathi Banda, Karen L McKim, Meagan B Myers, et al.
International Journal of Molecular Sciences|March 1, 2019
Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision OncologyMeagan B Myers, Karen L McKim, Malathi Banda, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 11, 2017
Ovarian effects of prenatal exposure to benzo[a]pyrene: Roles of embryonic and maternal glutathione statusUlrike Luderer, Meagan B Myers, Malathi Banda, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Business Continuity & Emergency Planning|June 15, 2017
Operational risk assessmentVicky L McKim
The Lamp|February 20, 1999
Applause for Sydney Hospital UnitD Erickson, L McKim, P Griswold
Environmental and Molecular Mutagenesis|July 30, 2017
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomasBarbara L Parsons, Karen L McKim, Meagan B Myers
Molecular Carcinogenesis|August 30, 2012
A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroidMeagan B Myers, Karen L McKim, Barbara L Parsons
Personalized Medicine|March 1, 2015
Low-frequency <i>KRAS</i> mutations are prevalent in lung adenocarcinomasMeagan B Myers, Karen L McKim, Fanxue Meng, et al.
Expert Review of Molecular Diagnostics|August 1, 2012
Hotspot oncomutations: implications for personalized cancer treatmentMeagan B Myers, Yiying Wang, Karen L McKim, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2020
ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver MutationsMeagan B Myers, Karen L McKim, Yiying Wang, et al.
Plos One|September 8, 2020
Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoidsMalathi Banda, Karen L McKim, Meagan B Myers, et al.
International Journal of Molecular Sciences|March 1, 2019
Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision OncologyMeagan B Myers, Karen L McKim, Malathi Banda, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 11, 2017
Ovarian effects of prenatal exposure to benzo[a]pyrene: Roles of embryonic and maternal glutathione statusUlrike Luderer, Meagan B Myers, Malathi Banda, et al.
Pageof 2